Insite Vision Inc (INSV) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
965 ATLANTIC AVE ALAMEDA, CA 94501 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 1,050 | 1,656 | 330 | 2,475 | 5,400 | 8,300 | |||
| Cash and cash equivalents | 1,050 | 1,656 | 330 | 2,475 | 4,353 | 3,251 | |||
| Short-term investments | 1,000 | 5,000 | |||||||
| Other undisclosed cash, cash equivalents, and short-term investments | 47 | 49 | |||||||
| Receivables | 363 | 349 | 360 | 301 | 1,146 | 1,026 | |||
| Deferred costs | 895 | 1,267 | 2,145 | 2,248 | |||||
| Other undisclosed current assets | 272 | 36 | 126 | 288 | 926 | 1,160 | |||
| Total current assets: | 2,580 | 3,308 | 816 | 3,064 | 9,617 | 12,734 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,518 | 1,597 | 1,678 | 1,749 | 1,803 | 1,431 | |||
| Total noncurrent assets: | 1,518 | 1,597 | 1,678 | 1,749 | 1,803 | 1,431 | |||
| TOTAL ASSETS: | 4,098 | 4,905 | 2,494 | 4,813 | 11,420 | 14,165 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,111 | 3,011 | 3,577 | 3,370 | 4,165 | 3,829 | |||
| Interest and dividends payable | 241 | 85 | |||||||
| Employee-related liabilities | 1,691 | 1,655 | 1,641 | 1,408 | 1,125 | 1,090 | |||
| Accounts payable | 539 | 611 | 891 | 542 | 807 | 394 | |||
| Accrued liabilities | 640 | 660 | 1,045 | 1,420 | 2,233 | 2,345 | |||
| Debt | 5,199 | 5,199 | 82,581 | 82,581 | |||||
| Derivative instruments and hedges, liabilities | 959 | 1,191 | 1,156 | 791 | 1,105 | 1,685 | |||
| Deferred revenue and credits | 1,000 | 1,000 | |||||||
| Other undisclosed current liabilities | 1,086 | 1,078 | 67 | (129) | (37,899) | (39,698) | |||
| Total current liabilities: | 10,355 | 10,479 | 5,800 | 5,032 | 49,952 | 48,397 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 1,000 | 1,224 | 224 | 201 | 201 | 1,076 | |||
| Deferred revenue and credits | 1,000 | 1,224 | 224 | 201 | 201 | 1,076 | |||
| Other undisclosed noncurrent liabilities | 882 | 704 | 1,751 | 1,802 | 848 | (154) | |||
| Total noncurrent liabilities: | 1,882 | 1,928 | 1,975 | 2,003 | 1,049 | 922 | |||
| Total liabilities: | 12,237 | 12,407 | 7,775 | 7,035 | 51,001 | 49,319 | |||
| Equity | |||||||||
| Equity, attributable to parent | (8,139) | (7,502) | (5,281) | (2,222) | (39,581) | (35,154) | |||
| Common stock | 1,320 | 1,320 | 1,320 | 1,320 | 1,320 | 1,320 | |||
| Additional paid in capital | 166,631 | 166,440 | 166,232 | 166,011 | 165,801 | 165,549 | |||
| Accumulated deficit | (176,090) | (175,262) | (172,833) | (169,553) | (206,702) | (202,023) | |||
| Total equity: | (8,139) | (7,502) | (5,281) | (2,222) | (39,581) | (35,154) | |||
| TOTAL LIABILITIES AND EQUITY: | 4,098 | 4,905 | 2,494 | 4,813 | 11,420 | 14,165 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3,376 | 352 | 360 | 6,349 | 1,153 | 1,068 | ||
| Revenue, net | 3,376 | 305 | 360 | 6,349 | 1,153 | 1,068 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (131) | (123) | (158) | (158) | (138) | (3) | ||
| Gross profit: | 3,245 | 229 | 202 | 6,191 | 1,015 | 1,065 | ||
| Operating expenses | (3,742) | (3,317) | (3,116) | (3,935) | (4,590) | (3,711) | ||
| Other undisclosed operating income | 103 | 105 | ||||||
| Operating income (loss): | (497) | (3,088) | (2,914) | 2,256 | (3,472) | (2,541) | ||
| Nonoperating income (expense) (Investment Income, Nonoperating) | 232 | 968 | (365) | 314 | 580 | (640) | ||
| Interest and debt expense | (372) | (220) | 35,999 | |||||
| Income (loss) from continuing operations: | (637) | (2,340) | (3,279) | 38,569 | (2,892) | (3,181) | ||
| Income (loss) before gain (loss) on sale of properties: | (637) | (2,340) | (3,279) | 38,569 | (2,892) | (3,181) | ||
| Net income (loss): | (637) | (2,340) | (3,279) | 38,569 | (2,892) | (3,181) | ||
| Other undisclosed net loss attributable to parent | (191) | (89) | (1,420) | (1,787) | (1,812) | |||
| Net income (loss) available to common stockholders, diluted: | (828) | (2,429) | (3,279) | 37,149 | (4,679) | (4,993) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (637) | (2,340) | (3,279) | 38,569 | (2,892) | (3,181) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (637) | (2,340) | (3,279) | 38,569 | (2,892) | (3,181) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.